Barclays’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
3,065,806
+2,489,273
+432% +$3.91M ﹤0.01% 2760
2025
Q4
$1.79M Buy
576,533
+304,827
+112% +$870K ﹤0.01% 3016
2025
Q3
$715K Sell
271,706
-67,086
-20% -$148K ﹤0.01% 3583
2025
Q2
$417K Buy
338,792
+93,692
+38% +$102K ﹤0.01% 3861
2025
Q1
$270K Buy
245,100
+245,000
+245,000% +$283K ﹤0.01% 3888
2024
Q4
$90 Sell
100
-20,964
-100% -$18K ﹤0.01% 5185
2024
Q3
$20.8K Sell
21,064
-748,564
-97% -$720K ﹤0.01% 4894
2024
Q2
$693K Buy
769,628
+769,528
+769,528% +$576K ﹤0.01% 2819
2024
Q1
$118 Hold
100
﹤0.01% 4995
2023
Q4
$91 Sell
100
-100
-50% -$74 ﹤0.01% 5171
2023
Q3
$166 Buy
200
+99
+98% +$114 ﹤0.01% 4533
2023
Q2
$121 Sell
101
-41,479
-100% -$51.7K ﹤0.01% 4437
2023
Q1
$52.4K Sell
41,580
-1,391,040
-97% -$2.66M ﹤0.01% 4433
2022
Q4
$3.11M Buy
1,432,620
+1,279,971
+839% +$10.5M ﹤0.01% 1957
2022
Q3
$1.83M Buy
152,649
+147,670
+2,966% +$1.83M ﹤0.01% 1810
2022
Q2
$41K Buy
+4,979
New +$38.6K ﹤0.01% 4110
2022
Q1
Sell
-72,450
Closed -$819K 5214
2021
Q4
$819K Buy
+72,450
New +$861K ﹤0.01% 2950
2021
Q3
Sell
-13,429
Closed -$109K 4847
2021
Q2
$109K Buy
13,429
+12,942
+2,657% +$112K ﹤0.01% 3813
2021
Q1
$5K Sell
487
-27,234
-98% -$275K ﹤0.01% 4482
2020
Q4
$268K Buy
+27,721
New +$273K ﹤0.01% 3598
2020
Q3
Sell
-52,714
Closed -$685K 5341
2020
Q2
$685K Buy
52,714
+51,745
+5,340% +$651K ﹤0.01% 3073
2020
Q1
$10K Buy
969
+960
+10,667% +$12.5K ﹤0.01% 5814
2019
Q4
$0 Sell
9
-86,188
-100% -$1.74M ﹤0.01% 6524
2019
Q3
$1.45M Buy
+86,197
New +$1.71M ﹤0.01% 3268
2019
Q2
Sell
-3,138
Closed -$68K 7054
2019
Q1
$68K Buy
+3,138
New +$65.4K ﹤0.01% 5663

Other funds holding GOSS